gatifloxacin has been researched along with Cancer of Mouth in 1 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, S | 1 |
| Agarwal, J | 1 |
| Laskar, S | 1 |
| Gupta, T | 1 |
| Shrivastava, S | 1 |
1 other study available for gatifloxacin and Cancer of Mouth
| Article | Year |
|---|---|
Radiation recall dermatitis with gatifloxacin: a review of literature.
Topics: Anti-Infective Agents; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Drug Eruptio | 2008 |